NEWS / BLOG
Gentronix News and Blog section gives you our latest company updates, comments on the field of toxicology and insights into our business, values and commitment to our clients.
LATEST NEWS
Gentronix Bolsters Executive Team To Drive Continued Growth
UK-based Contract Research Organisation (CRO) Gentronix – the largest independent genetic toxicology CRO in Europe - has appointed a new Operations Director to accelerate its strategic [...]
EFSA Opinion on Agrochemical Groundwater Metabolite Testing Data Gap May Pose a Concern for Legacy Pesticide Registrations
Last month the European Food Safety Authority (EFSA) published a summary of the conclusions on recurring issues in pesticide mammalian toxicology in the EFSA Journal. This was a summar [...]
COVID-19 & Business Continuity
Gentronix Ltd continues to be open for business and is currently operating as normal, at the same time heeding the advice of the UK Government. Whilst clear challenges for all business [...]
BLOG
Benefits of a combination of 24-well Ames and 96-well MNT assays
Including genetic toxicology in the early drug discovery phase is a key step in improving the safety profile of the chemical series under development and increasing the chances of proj [...]
A brief introduction to the KeratinoSens™ assay
The 2nd key event in the skin sensitisation AOP considers whether a single chemical, formulation or mixture can induce activation of keratinocytes and the associated inflammatory respo [...]
Using the DPRA assay to generate GLP study data
Within the skin sensitisation adverse outcome pathway, the first key event is based on the premise that a chemical can become a skin sensitiser via interaction with skin proteins, form [...]
OUR VALUES
OUR VALUES
Our business origins are in the delivery of innovative screening products for toxicological hazard; challenging the established approach with scientific rigour. Building on our experiences of developing market leading predictive toxicology assays, we have extended our expertise to the regulatory tests for genetic toxicology and recently skin sensitisation.
We make a commitment to our clients to perform toxicology studies of the highest scientific quality; not merely to produce data, but to deliver the most appropriate data endpoints, using the right assay tools, guided by scientific engagement and experience. Furthermore, we are committed to helping our clients understand and interpret their results, supporting navigation of regulatory landscapes and management of adverse toxicology findings.
This is guided by our core values, which we apply to all the studies we perform:
Our business origins are in the delivery of innovative screening products for toxicological hazard; challenging the established approach with scientific rigour. Building on our experiences of developing market leading predictive toxicology assays, we have extended our expertise to the regulatory tests for genetic toxicology and recently skin sensitisation.
We make a commitment to our clients to perform toxicology studies of the highest scientific quality; not merely to produce data, but to deliver the most appropriate data endpoints, using the right assay tools, guided by scientific engagement and experience. Furthermore, we are committed to helping our clients understand and interpret their results, supporting navigation of regulatory landscapes and management of adverse toxicology findings.
This is guided by our core values, which we apply to all the studies we perform:
LATEST VACANCIES
At Gentronix, we have a passion for the science of toxicology. Building on our experience gained from the pharmaceutical, agrochemical and CRO industries, we are committed to engaging with our clients to deliver the highest quality to science to support their projects. If believe you have the toxicology knowledge and the interest to support us in delivering this commitment, we’re interested to learn more.